US · Healthcare · Medical Devices
EPS came in at -0.29 against a street estimate of -0.37 — a beat of 21.6%.
Analysts rate Rxsight Inc a hold (1 buy, 7 hold, 2 sell out of 10) with an average price target of $7.57.
| Fund | Stake |
|---|---|
| BlackRock Inc | 13.92% |
| Millennium Management LLC | 7.29% |
| No Street GP LP | 4.94% |
| Nomura Holdings Inc | 4.81% |
| D. E. Shaw & Co LP | 4.77% |
| Vanguard Capital Management, LLC | 4.03% |
| AQR Capital Management LLC | 3.69% |
| Acadian Asset Management LLC | 3.61% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Rxsight Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.